criteria for admission to this particular study include ( 1 ) a solitary focus of plasmacytoma proven by biopsy , ( 2 ) normal bone marrow findings ( less than 10 % plasma cells ) , and ( 3 ) no evidence of disseminated disease .
C0032131
solitary
C0032112
plasma cells